Awareness of biosimilars among U.S. specialty physicians is high but new survey identifies five major knowledge gaps. The results of a survey show that although the majority of specialty physicians surveyed have heard about biosimilars1, there are notable gaps in their knowledge about biosimilar concepts.  The survey, designed by the Biosimilars Forum and conducted by…